• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3 β/AMPK/NLRP3 inflammasome pathway

    2021-09-23 16:43:10JunLingPuZuoTinHungYunHiLuoTongMouTingTingLiZhongTngLiXuFuWeiZhongJunWu

    Jun-Ling Pu ,Zuo-Tin Hung ,Yun-Hi Luo ,Tong Mou ,Ting-Ting Li ,Zhong-Tng Li ,Xu-Fu Wei,Zhong-Jun Wu,*

    a Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 40 0 016, China

    b Department of Anatomy, Basic Medical College, Chongqing Medical University, Chongqing 40 0 016, China

    Keywords:Fisetin Hepatic ischemia-reperfusion injury GSK3 β AMPK NLRP3

    ABSTRACT Background: Hepatic ischemia-reperfusion (I/R) injury (IRI) represents a crucial challenge in liver transplantation.Fisetin has anti-inflammatory,anti-aging and anti-oxidative properties.This study aimed to examine whether fisetin mitigates hepatic IRI and examine its underlying mechanisms.Methods: Sham or warm hepatic I/R operated mice were pretreated with fisetin (5,10 or 20 mg/kg).Hepatic histological assessments,TUNEL assays and serum aminotransferase measurements were performed.An in vitro hypoxia/reoxygenation (H/R) model using RAW264.7 macrophages pretreated with fisetin (2.5,5 or 10 μmol/L) was also used.Serum and cell supernatant concentrations of interleukin-1 β (IL-1 β),IL-18 and tumor necrosis factor-α (TNF-α) were determined by enzyme-linked immunosorbent assay (ELISA).Protein levels of p-GSK3 β,p-AMPK and NLR family pyrin domain-containing 3 (NLRP3)-associated proteins were detected by Western blotting.Results: Compared with the I/R group,fisetin pretreatment reduced pathological liver damage,serum aminotransferase levels,serum concentrations of IL-1 β,IL-18 and TNF-α in the murine IRI model.Fisetin also reduced the expression of NLRP3 inflammasome-associated proteins (NLRP3,cleaved caspase-1,IL-1 β and IL-18) in I/R-operated liver.The experiments in vitro showed that fisetin decreased the release of IL-1 β,IL-18 and TNF-α,and reduced the expression of NLRP3 inflammasome-associated proteins in H/R-treated RAW264.7 cells.Moreover,fisetin increased the expressions of p-GSK3 β and p-AMPK in both models,indicating that its anti-inflammatory effects were dependent on GSK3 β/AMPK signaling.The antiinflammatory effects of fisetin were partially inhibited by the AMPK specific inhibitor compound C.Conclusions: Fisetin showed protective effects against hepatic IRI,countering inflammatory responses through mediating the GSK3 β/AMPK/NLRP3 inflammasome pathway.

    Introduction

    Hepatic ischemia-reperfusion (I/R) injury (IRI) represents a crucial challenge for patients undergoing liver surgical procedures,especially for liver transplants [1] .Increased ischemia time and exacerbated hepatic IRI may cause postoperative complications including early graft dysfunction and graft rejection,threatening the survival of patients [2,3].The underlying physiopathology of I/R damage is complex,and excessive inflammatory response was considered a critical process during I/R [4,5].As an essential tissue-damage detector,the NLR family pyrin domain-containing 3(NLRP3) inflammasome is prominent for initiating and amplifying the inflammatory response.Moreover,accumulating evidence implicates the involvement of NLRP3 inflammasome in the pathogenesis of hepatic IRI [6-8].

    The NLRP3 inflammasome is activated when cellular homeostasis is disturbed,either through endogenous (tissue injury)or pathogenic (infection) signals,followed by caspase-1 autoactivation.Thereafter,caspase-1 processes precursor interleukin-1β(proIL-1β) and proIL-18 into active forms,followed with their release [9,10].With respect to relieving hepatic I/R damage,potential therapeutic targets have been identified,including the glycogen synthase kinase 3β(GSK3β) [11] .GSK3βregulates various physiological processes including metabolism,apoptosis,and immunoregulation [12] .As a constitutively active protein kinase,the enzymatic activity of GSK3βis inhibited by phosphorylation at Ser9 and enhanced by phosphorylation at Tyr216.It is noteworthy that GSK3βinhibition through Ser9 phosphorylation has been demonstrated to successfully relieve hepatic IRI [11] .In addition,GSK3βalso regulates the activity of adenosine monophosphateactivated protein kinase (AMPK),a well-known metabolic regulator [13] .AMPK was shown to alleviate hepatic IRI through inhibiting macrophage activation [14] .The recent evidence suggests that the NLRP3 inflammasome might be regulated by AMPK in macrophages [15] .Thus,this collective evidence proposes that NLRP3 inflammasome regulation occurs through the GSK3β/AMPK pathway.

    Fisetin is a plant bioflavonoid extracted from fruits,including apples,strawberries and persimmons.It was shown to have therapeutic potential in cancer,inflammatory and metabolic diseases [16] .Furthermore,several studies indicated that fisetin could mitigate myocardial IRI [17,18].Interestingly,fisetin was documented to have a regulatory effect on GSK3βand AMPK [17,19].The present study was to define the potential of fisetin to alleviate hepatic IRI,particularly its actions against GSK3β/AMPK/NLRP3 inflammasome signaling.

    Materials and methods

    Preparation of fisetin

    Fisetin (purity>98%) provided by MedChemExpress (Monmouth Junction,NJ,USA) was dissolved by DMSO (Sigma,St.Louis,MO,USA) and further diluted by saline or cell culture medium before use.

    Animals

    Male C57BL/6J mice (weighing 25-28 g) were supplied by the Experimental Animal Center of Chongqing Medical University (Chongqing,China).The animals were bred under specific pathogen-free conditions.All animal experiments were authorized by the Ethics Committee of The First Affiliated Hospital of Chongqing Medical University (2020-514).

    Surgical procedures

    Thirty C57BL/6J mice were randomized into six groups (n=5 each group):sham group,sham+FIS-20 group (sham with 20 mg/kg fisetin pretreatment),I/R group (I/R operation alone),and I/R with three concentrations of fisetin pretreatment groups (5,10 or 20 mg/kg,respectively).Mice were anesthetized with pentobarbital (40 mg/kg,Merck,Kenilworth,NJ,USA) by intraperitoneal injection.For I/R operation groups,a 70% warm hepatic I/R surgery was performed as described [20] .Briefly,the portal vein and hepatic artery were occluded by arterial clips for 1 h and then reperfused for 6 h.The sham group underwent similar procedures without clamping.For fisetin pretreatment groups,fisetin was administered intraperitoneally 0.5 h before operation.All mice were sacrificed after 6 h upon reperfusion.

    Macrophage culture

    RAW264.7 macrophages were provided by Cell Bank of the Type Culture Collection of the Chinese Academy of Sciences and cultured in Dulbecco’s Modified Eagle’s Medium (Gibco,Grand Island,NY,USA) containing 10% fetal bovine serum (HyClone,Logan,Utah,USA) at 37 °C and 5% CO2.

    Hypoxia/reoxygenation (H/R) in vitro model

    RAW264.7 macrophages were exposed to hypoxic culture conditions for 6 h (1% O2and 5% CO2) in a triple gas incubator(Thermo,Waltham,MA,USA) before storing cells to normoxia for 6 h as previously described [20] .Cells were treated with 2.5,5 or 10 μmol/L fisetin during H/R along with the AMPK inhibitor compound C (Comp.C;MedChemExpress) with the following experimental groups used:control group,FIS-10 group (10 μmol/L fisetin),H/R group,H/R+FIS-2.5 group (H/R with 2.5 μmol/L fisetin),H/R+FIS-5 group (5 μmol/L fisetin),H/R+FIS-10 group(10 μmol/L fisetin),H/R+Comp.C group (10 μmol/L compound C) and H/R+FIS-10+Comp.C group (10 μmol/L fisetin and compound C,respectively).Cell lysates and supernatants were obtained for further analysis.

    Hematoxylin and eosin (HE) staining and TUNEL assays

    Paraformaldehyde-fixed paraffin-embedded liver tissue specimens were sectioned and subjected to standard HE staining.Afterwards,the severity of hepatic pathological impairment was evaluated by the Suzuki’s injury scoring system [21] .For assessment of apoptosis,sections were stained using the TUNEL kit (Roche,Basel,Switzerland) following the manufacturer’s illustrations.

    Aminotransferase assay

    Serum samples were used to analyze the concentrations of alanine aminotransferase (ALT) and aspartate aminotransferase (AST)using special aminotransferase assay kits (Nanjing Jiancheng Bioengineering Institute,Nanjing,China) following the manufacturer’s instructions.

    Cytokines determination

    IL-1β,IL-18 and tumor necrosis factor-α(TNF-α) concentrations in serum and cell supernatants were determined by enzyme-linked immunosorbent assay (ELISA) kits (Neobioscience,Beijing,China)following the manufacturer’s instructions.

    Western blotting

    Tissue and cell lysates were prepared using the RIPA kit(Boster,Wuhan,China) [22] .Equal amounts of soluble protein(measured by BCA method) were resolved by SDS-PAGE,transferred to PVDF membranes before analysis by Western blotting using antibodies directed against p-GSK3β(Ser9,Bioss,Beijing,China),GSK3β(Proteintech,Wuhan,China),p-AMPK (Thr172,ABclonal,Wuhan,China),AMPK (Proteintech),NLRP3 (Bioss),IL-1β(Wanleibio,Shanghai,China),proIL-1β(Wanleibio),IL-18 (Proteintech),proIL-18 (Bioss),cleaved caspase-1 (Abcam,Cambridge,UK),caspase-1 (Abcam) andβ-actin (Proteintech).

    Statistical analysis

    Data analyses were performed using GraphPad Prism v8.0(GraphPad Software,San Diego,CA,USA).All data were expressed as mean ± standard deviation (SD).One-way analysis of variance(ANOVA) tests with Turkey’sposthoctests were used to identify statistical differences among multiple groups.APvalue<0.05(two-tailed) was defined as statistically significant.

    Fig.1.Fisetin improves liver function and decreases inflammatory cytokines after I/R operation in mice.n=5/group.** P < 0.01,vs.Sham;## P < 0.01,vs.I/R.

    Results

    Fisetin improves liver function and decreases inflammatory cytokines after I / R operation

    As the primary diagnostic parameters of liver function,serum ALT and AST concentrations were significantly elevated after the 70% warm hepatic I/R operation.Notably,pretreatment with increasing doses of fisetin (5,10 or 20 mg/kg) gradually reduced ALT and AST concentrations compared to those of the I/R group (Fig.1 A and B,P<0.01),suggesting that fisetin alleviated hepatic IRI.

    As shown in Fig.1 C-E,we observed significantly increases in IL-1β,IL-18 and TNF-αafter I/R surgery (P<0.01).However,fisetin pretreatment (5,10 or 20 mg/kg) gradually attenuated the increased concentrations of these cytokines compared to those of the I/R group (P<0.01).

    Fisetin decreases the severity of histopathological changes in the I/R model

    Examination of liver sections from the sham group revealed liver lobule structures arranged in an orderly manner,the hepatic cords were clear and there was almost no hepatic injury or necrosis (Fig.2 A).Similar findings were observed in the sham+FIS-20 group,indicating that fisetin had no impact on the normal liver condition.In contrast,representative pathological changes including coagulation necrosis,severe architectural abnormalities,sinusoid congestion and vacuolization were found after I/R operation.Instructively,fisetin pretreatment (5,10 or 20 mg/kg) significantly reduced these hepatic pathological changes.These findings were confirmed after assessing liver sections using Suzuki’s scores(Fig.2 C).

    Fisetin attenuates hepatocyte apoptosis

    Consistent with the results of HE staining,the sham and the sham+FIS-20 groups had few TUNEL positive cells which dramatically increased after I/R operation (Fig.2 B).However,compared to the I/R group,fisetin pretreatment (5,10 or 20 mg/kg) reduced the number of TUNEL positive cells in a dose-dependent manner(Fig.2 B and D,P<0.01).

    Fisetin regulates the GSK3 β/AMPK/NLRP3 inflammasome pathway in the I / R model

    After the I/R procedure,liver tissues exhibited significant increase in the expression of NLRP3,cleaved caspase-1,IL-1βand IL-18 compared to those of the sham group,while p-GSK3β(Ser9)and p-AMPK (Thr172) protein expressions were decreased (Fig.3,P<0.01).However,fisetin pretreatment (5,10 or 20 mg/kg) gradually diminished the activation of NLRP3 inflammasome-associated proteins along with the elevated levels of p-GSK3β(Ser9) and p-AMPK (Thr172) (Fig.3,P<0.05).

    Fisetin mitigates H/R-induced inflammation via the GSK3 β/AMPK/NLRP3 inflammasome pathway in vitro

    Notably,we observed significantly elevated IL-1β,IL-18 and TNF-αproduction in cell supernatants after exposure to H/R conditions (Fig.4 A-C,P<0.01).Remarkably,fisetin treatment (2.5,5 or 10 μmol/L) gradually diminished the concentrations of these cytokines (Fig.4 A-C,P<0.05).

    Indeed,H/R exposure resulted in significant elevations in the protein levels of NLRP3,cleaved caspase-1,IL-1βand IL-18,while the expressions of p-GSK3β(Ser9) and p-AMPK (Thr172) were diminished (Fig.4 D-J,P<0.01).Treatment with fisetin (2.5,5 or 10 μmol/L) gradually diminished activation of the NLRP3 inflammasome as indicated by inhibition of the increased levels of NLRP3,cleaved caspase-1,IL-1βand IL-18,and enhancement of p-GSK3β(Ser9) and p-AMPK (Thr172) expression (Fig.4 D,P<0.05).

    Fig.2.Fisetin attenuates hepatic histopathological changes and hepatocyte apoptosis after I/R operation in mice.A and C:Representative HE liver sections (original magnification × 200) and Suzuki’s score results of the different treatment groups;B and D:representative TUNEL staining of liver sections (original magnification × 400) and estimation of TUNEL positive cell numbers.n=5/group.** P < 0.01,vs.Sham;## P < 0.01,vs.I/R.

    Fig.3.Fisetin regulates GSK3 β/AMPK/NLRP3 inflammasome proteins in the liver I/R model.A:Representative Western blotting of p-GSK3 β (Ser9),p-AMPK (Thr172) and NLRP3 inflammasome-associated proteins in mouse liver tissues among the treatment groups.B-G:Quantitative analysis of all samples from A .n=5/group.** P < 0.01,vs.Sham;# P < 0.05,## P < 0.01,vs.I/R.

    Protective effects of fisetin are attenuated after inhibiting AMPK

    Compared to the H/R+FIS-10 (H/R+10 μmol/L fisetin) group,compound C significantly elevated the inflammatory cytokines(Fig.5 A-C,P<0.01).Moreover,Western blotting analysis indicated that compared with the H/R+FIS-10 group,compound C treatment (H/R+FIS-10+Comp.C group) significantly boosted the expression of NLRP3,cleaved caspase-1,IL-1βand IL-18,and reduced the p-AMPK (Thr172) expression (Fig.5 D-J,P<0.05).However,compound C treatment did not entirely block the regulation effect of fisetin on NLRP3 inflammasome.Interestingly,there was no significant difference in the expression of p-GSK3β(Ser9) between the two groups (Fig.5 D and E,P>0.05),suggesting that GSK3β(Ser9) phosphorylation was not regulated by AMPK in this scenario.

    Discussion

    As an inevitable obstacle in liver transplant operations,hepatic IRI has attracted considerable attention.As is commonly known,a longer ischemia time implies a higher risk of postoperative complications and worse prognosis [23] .Our previous studies indicated that inhibiting inflammatory reactions by targeting proinflammatory molecules may mitigate hepatic IRI [20,24].Thus,pharmacological interventions targeting specific molecules may contribute to the development of hepatic IRI treatments.Herein,we verified that fisetin improved liver function,decreased inflammatory cytokines and attenuated hepatic histopathological changesinvivo,as well as suppressing inflammatory actionsinvitro.Moreover,we link the protective effects of fisetin with regulation of the GSK3β/AMPK/NLRP3 inflammasome pathway.Our findings may provide some support for the clinical treatment of hepatic IRI.

    Fig.4.Fisetin inhibits inflammation in H/R-exposed macrophages by regulating the GSK3 β/AMPK/NLRP3 inflammasome pathway.A-C:Production of IL-1 β,IL-18 and TNF-α in RAW264.7 macrophages was measured by ELISA in the indicated treatment groups;D-J:relative expression of p-GSK3 β (Ser9),p-AMPK (Thr172) and NLRP3 inflammasome-associated proteins in the cells from A .** P < 0.01,vs.Control;# P < 0.05,## P < 0.01,vs.H/R.

    The most salient finding of our study involved the proved benefit of fisetin in relieving hepatic IRI by suppressing inflammatory reactions.This is consistent with previous studies which found that fisetin could alleviate I/R damage in other organs albeit through alternative mechanisms.Garg et al.[18] reported that fisetin reduced apoptosis,oxidative stress,and inflammation in myocardial infarction model by modulating PPAR-γas well as the NF-κB pathway.Zhang and Cui [25] also demonstrated that fisetin alleviated cerebral IRI by suppressing the NF-κB activity via inflammatory and antioxidant pathways.Besides,fisetin was reported to have protective effects in liver diseases.For instance,fisetin mitigated nonalcoholic fatty liver disease by suppressing the TNF-α/RIPK3 pathway mediated inflammation [26] .Our study now implicates the NLRP3 inflammasome as a critical target of fisetin in liver,and together with these prior studies highlights fisetin as a candidate for treating hepatic inflammation induced by different diseases.

    Fig.5.Inhibition of AMPK by compound C (10 μmol/L) partially alleviates the anti-inflammatory ability of fisetin in vitro .A-C:RAW264.7 macrophages were treated as indicated (FIS-10;10 μmol/L),and production of IL-1 β,IL-18 and TNF-α was measured by ELISA;D-J:relative expression of p-GSK3 β (Ser9),p-AMPK (Thr172) and NLRP3 inflammasome-associated proteins in the cells from A .* P < 0.05,** P < 0.01,NS P > 0.05.

    Much literature involving hepatic IRI emphasizes the significance of the NLRP3 inflammasome,especially its critical role in maturation and release of detrimental cytokines [9,10,27].As expected,we observed the elevated expression of NLRP3 inflammasome-associated proteins in bothinvivoandinvitromodels,which coincided with the enhanced production of IL-1βand IL-18.Moreover,we found that fisetin suppressed the activation of the NLRP3 inflammasome and concomitant release of downstream inflammatory cytokines in hepatic IRI.Consistently,albeit in the context of a diabetic nephropathy model,it was found that fisetin supplementation reduced NLRP3 expression in high fat diet-fed mice [28] .

    We also observed that GSK3βactivity was increased by I/R operation,manifested by decreased inhibitory phosphorylation expression of GSK3βat Ser9.Similar to previous reports,fisetin treatment suppressed GSK3βactivity through increasing p-GSK3β(Ser9) expression [17,29].GSK3βis documented to control glucose metabolism and inflammatory reaction [30,31],and may exert immune-regulatory effects by direct control of proinflammatory molecules,or by altering the cellular metabolism of immune cells to influence their activation or differentiation [11,32].In macrophages,toxins increase GSK3βactivity and activate NLRP3 inflammasome,while GSK3βinhibitors can suppress these effects [33] .Besides,inhibiting GSK3βmay protect against hepatic IRI by regulating antioxidant response and mitochondrial permeability transition [34] .Moreover,GSK3βinhibition contributes to elevated CREB activity and IL-10 production,as well as diminished NF-κB activity,which together can minimize inflammation and liver damage [11,35].

    As a central regulator of cellular energy metabolism,activation of AMPK exerts anti-inflammatory effects in various inflammatoryrelated diseases [36-38].Notably,Qing et al.[39] showed that activating AMPK could suppress the NLRP3 inflammasome by boosting M2 macrophage polarization via mTOR.Wang et al.[40] also showed that suppressing AMPK/mTOR-mediated autophagy activates the NLRP3 inflammasome in Kupffer cells.Of relevance,fisetin was reported to activate AMPK/mTOR signaling in pancreatic cancer cells [41] .In this study,we confirmed that fisetin suppressed NLRP3 inflammasome through AMPK signaling in liver tissue and murine macrophages.Interestingly,the activation of AMPK in macrophages was documented to be regulated by GSK3β[11] .On the contrary,AMPK was also reported to regulate the activity of GSK3βin macrophages [42] .However,we observed that pharmacological inhibition of AMPK did not influence the inhibitory effects of fisetin on GSK3β,nor did it entirely reverse the effects of fisetin on the NLRP3 inflammasome.While our data firmly invoke a role for the GSK3β/AMPK pathway in the fisetin-mediated regulation of the NLRP3 inflammasome,the latter finding suggests that GSK3βinhibition is at least partially uncoupled from AMPK.This further suggests that other pathways must be involved.

    Finally,we must acknowledge the limitations of our study.The pathophysiological process of IRI is complex and cannot be explained by inflammation alone.Moreover,the mouse model used a standardized I/R time and therefore more experiments are required to determine the extent of benefit provided by fisetin under different ischemia time that produce different degrees of IRI.Furthermore,there are other properties of fisetin that we have not considered in our analysis including antioxidant activity.

    In summary,we validated that fisetin protects the liver against IRI.Additionally,fisetin suppressed GSK3β,accompanied by AMPK activation,leading to NLRP3 inflammasome suppression and diminished pro-inflammatory cytokines productions.This body of work suggests fisetin intervention as a new strategy to treat hepatic IRI.

    Acknowledgments

    None.

    CRediTauthorshipcontributionstatement

    Jun-LiangPu:Data curation,Formal analysis,Writing -original draft.Zuo-TianHuang:Data curation,Formal analysis,Writing -original draft.Yun-HaiLuo:Data curation,Software,Writing-review &editing.TongMou:Data curation,Software,Writing -review &editing.Ting-TingLi:Data curation,Methodology,Writing -review &editing.Zhong-TangLi:Data curation,Methodology,Writing -review &editing.Xu-FuWei:Writing -review &editing.Zhong-JunWu:Conceptualization,Funding acquisition,Supervision,Writing -review &editing.

    Funding

    This study was supported by grants from the National Natural Science Foundation of China (81672959,81873592 and 81703063),the Science and Technology Commission Foundation of Chongqing,China (cstc2019jscx-gksbX0005),the Natural Science Foundation of Chongqing,China (cstc2018jscx-msybX0133) and the graduate tutor team construction project of Chongqing Municipal Education Commission Foundation,China (dstd201801).

    Ethicalapproval

    This study was approved by the Ethics Committee of The First Affiliated Hospital of Chongqing Medical University (2020-514).

    Competinginterest

    No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    久久鲁丝午夜福利片| 国产乱来视频区| 亚洲va在线va天堂va国产| 女人十人毛片免费观看3o分钟| 亚洲av免费在线观看| 日韩中字成人| 男的添女的下面高潮视频| 免费无遮挡裸体视频| 日韩欧美在线乱码| 高清毛片免费看| 韩国高清视频一区二区三区| 麻豆乱淫一区二区| 最后的刺客免费高清国语| 丰满乱子伦码专区| 国产视频首页在线观看| 国产亚洲最大av| 免费av毛片视频| 人人妻人人澡欧美一区二区| 大话2 男鬼变身卡| 老司机影院毛片| 国产伦在线观看视频一区| 秋霞伦理黄片| 亚洲三级黄色毛片| 成人美女网站在线观看视频| 国产大屁股一区二区在线视频| 亚洲人成网站在线播| 亚洲欧美精品综合久久99| 亚洲精品456在线播放app| 国产麻豆成人av免费视频| 午夜免费激情av| 一区二区三区免费毛片| 性色avwww在线观看| 欧美成人a在线观看| 久久久精品欧美日韩精品| 麻豆国产97在线/欧美| av又黄又爽大尺度在线免费看 | 国内精品一区二区在线观看| 秋霞伦理黄片| 97超碰精品成人国产| 国产免费又黄又爽又色| 国产色婷婷99| av在线老鸭窝| 免费一级毛片在线播放高清视频| 国产伦一二天堂av在线观看| 亚洲成人av在线免费| 日韩欧美精品免费久久| 成人av在线播放网站| 老师上课跳d突然被开到最大视频| 高清视频免费观看一区二区 | av在线蜜桃| 久久精品夜夜夜夜夜久久蜜豆| 色噜噜av男人的天堂激情| 一个人看的www免费观看视频| 激情 狠狠 欧美| 久久久成人免费电影| av播播在线观看一区| 黄片无遮挡物在线观看| 久久亚洲精品不卡| 在线免费观看的www视频| 久久精品影院6| 亚洲内射少妇av| 一级二级三级毛片免费看| 天美传媒精品一区二区| 偷拍熟女少妇极品色| 六月丁香七月| 丝袜美腿在线中文| 久久99热这里只频精品6学生 | 91在线精品国自产拍蜜月| 一区二区三区四区激情视频| 亚洲五月天丁香| 免费观看的影片在线观看| 欧美xxxx性猛交bbbb| 麻豆av噜噜一区二区三区| 久久精品国产亚洲网站| 久久精品久久久久久久性| 超碰97精品在线观看| 久久精品国产鲁丝片午夜精品| 中文字幕久久专区| 日韩成人伦理影院| 欧美人与善性xxx| 黄色日韩在线| 国产极品精品免费视频能看的| 两个人的视频大全免费| 亚洲真实伦在线观看| 欧美日韩精品成人综合77777| 菩萨蛮人人尽说江南好唐韦庄 | 日日干狠狠操夜夜爽| av视频在线观看入口| 一个人观看的视频www高清免费观看| 18禁裸乳无遮挡免费网站照片| 美女cb高潮喷水在线观看| 国产精品美女特级片免费视频播放器| 麻豆精品久久久久久蜜桃| 色尼玛亚洲综合影院| 国产一级毛片在线| 精品人妻一区二区三区麻豆| av黄色大香蕉| 青春草视频在线免费观看| 看片在线看免费视频| 日韩,欧美,国产一区二区三区 | 亚洲最大成人av| 69人妻影院| 久久国内精品自在自线图片| 三级毛片av免费| 一卡2卡三卡四卡精品乱码亚洲| 亚洲三级黄色毛片| 国产免费男女视频| av.在线天堂| 日韩av在线免费看完整版不卡| 国产一区二区在线观看日韩| 日日撸夜夜添| 国产精品爽爽va在线观看网站| av国产久精品久网站免费入址| 国产人妻一区二区三区在| 欧美另类亚洲清纯唯美| 黄色欧美视频在线观看| 欧美高清成人免费视频www| 黄色配什么色好看| h日本视频在线播放| 欧美精品一区二区大全| 少妇人妻一区二区三区视频| 日日撸夜夜添| a级毛片免费高清观看在线播放| 日日摸夜夜添夜夜爱| 国产亚洲精品久久久com| 日本黄色片子视频| 国产乱人偷精品视频| 啦啦啦韩国在线观看视频| 久久久久久久久中文| 亚洲经典国产精华液单| 国产乱人视频| 国产不卡一卡二| 天堂√8在线中文| 欧美性猛交╳xxx乱大交人| 亚洲aⅴ乱码一区二区在线播放| videossex国产| 国产中年淑女户外野战色| 国产综合懂色| 尾随美女入室| 国产精品一区二区在线观看99 | 亚洲国产日韩欧美精品在线观看| 岛国毛片在线播放| 两个人的视频大全免费| 精品人妻视频免费看| 亚洲一级一片aⅴ在线观看| 男女国产视频网站| 日本爱情动作片www.在线观看| 国产真实乱freesex| 色视频www国产| 99热这里只有是精品50| 国产探花在线观看一区二区| 国产又色又爽无遮挡免| 日本熟妇午夜| 国产免费福利视频在线观看| 日韩中字成人| 国产成人福利小说| 两个人视频免费观看高清| 在现免费观看毛片| 美女高潮的动态| 国产成人a区在线观看| 色5月婷婷丁香| 国产老妇女一区| 国产精品国产三级专区第一集| 亚洲怡红院男人天堂| 中国国产av一级| 亚洲欧美日韩高清专用| 中文字幕制服av| 中文字幕av在线有码专区| 人体艺术视频欧美日本| 男的添女的下面高潮视频| 精品一区二区免费观看| 亚洲av电影在线观看一区二区三区 | 中文欧美无线码| 亚洲av成人精品一二三区| 99久久中文字幕三级久久日本| 少妇猛男粗大的猛烈进出视频 | 日本-黄色视频高清免费观看| 亚洲自拍偷在线| 日韩大片免费观看网站 | 午夜激情欧美在线| 国产淫语在线视频| 成年版毛片免费区| 国产亚洲5aaaaa淫片| 国产精品久久久久久精品电影| 舔av片在线| 免费观看的影片在线观看| 久久精品久久久久久久性| 最近最新中文字幕大全电影3| 日本熟妇午夜| 国内少妇人妻偷人精品xxx网站| 日日撸夜夜添| 久久99热这里只频精品6学生 | 亚洲精品一区蜜桃| 久久亚洲国产成人精品v| 午夜福利网站1000一区二区三区| 少妇被粗大猛烈的视频| 99在线人妻在线中文字幕| 欧美成人一区二区免费高清观看| 亚洲激情五月婷婷啪啪| 美女大奶头视频| 国产一区二区亚洲精品在线观看| 亚洲婷婷狠狠爱综合网| 亚洲成人久久爱视频| 国产成人a区在线观看| 天天一区二区日本电影三级| 国产av在哪里看| 九色成人免费人妻av| 18禁裸乳无遮挡免费网站照片| 亚洲精品乱码久久久v下载方式| 亚洲,欧美,日韩| 又粗又爽又猛毛片免费看| 国产精品一区二区三区四区久久| 一本久久精品| 天堂影院成人在线观看| 久久久久久久久久久免费av| 亚洲欧美精品专区久久| 嫩草影院精品99| 一级黄片播放器| 国产探花在线观看一区二区| 天堂中文最新版在线下载 | 成人av在线播放网站| 亚洲精品乱码久久久v下载方式| 麻豆成人av视频| 午夜日本视频在线| 高清日韩中文字幕在线| videossex国产| 老师上课跳d突然被开到最大视频| 国产精品.久久久| 五月伊人婷婷丁香| 日本免费a在线| 国产精品一区www在线观看| 夜夜爽夜夜爽视频| 国产极品精品免费视频能看的| 97超视频在线观看视频| 亚洲国产最新在线播放| 亚洲不卡免费看| 高清视频免费观看一区二区 | 五月伊人婷婷丁香| 18禁在线播放成人免费| 亚洲欧美日韩高清专用| 久久久精品大字幕| 日本免费在线观看一区| 菩萨蛮人人尽说江南好唐韦庄 | 国产精品美女特级片免费视频播放器| 高清在线视频一区二区三区 | 国产成人精品婷婷| 丰满少妇做爰视频| 高清毛片免费看| 两性午夜刺激爽爽歪歪视频在线观看| 人人妻人人澡欧美一区二区| 噜噜噜噜噜久久久久久91| a级毛色黄片| 国产伦精品一区二区三区四那| 日韩欧美 国产精品| av又黄又爽大尺度在线免费看 | 国产成人a区在线观看| 日本免费在线观看一区| 国产私拍福利视频在线观看| 亚洲高清免费不卡视频| 九九爱精品视频在线观看| 看免费成人av毛片| 黄片wwwwww| 美女内射精品一级片tv| 久久久久久久久久久丰满| 你懂的网址亚洲精品在线观看 | 亚洲欧美精品综合久久99| 国产精品乱码一区二三区的特点| 国产av在哪里看| 嫩草影院精品99| 久久99热6这里只有精品| 亚洲在久久综合| 免费播放大片免费观看视频在线观看 | 免费观看人在逋| 久久久久久久国产电影| 免费av不卡在线播放| 最近最新中文字幕免费大全7| 能在线免费看毛片的网站| 久久久a久久爽久久v久久| 亚洲第一区二区三区不卡| 高清av免费在线| 欧美xxxx性猛交bbbb| 高清视频免费观看一区二区 | 看十八女毛片水多多多| 国内揄拍国产精品人妻在线| 18禁裸乳无遮挡免费网站照片| 精品人妻一区二区三区麻豆| 美女脱内裤让男人舔精品视频| 国产精品人妻久久久影院| 能在线免费观看的黄片| 欧美日本视频| 亚洲成人精品中文字幕电影| 18禁在线播放成人免费| 三级国产精品片| 少妇的逼水好多| 97人妻精品一区二区三区麻豆| 日韩av在线大香蕉| 国产又黄又爽又无遮挡在线| 欧美日韩一区二区视频在线观看视频在线 | 亚洲av免费在线观看| 久久久久网色| 99热精品在线国产| 男人舔奶头视频| 搡老妇女老女人老熟妇| 极品教师在线视频| 黄色一级大片看看| 99久久精品热视频| 六月丁香七月| 男女那种视频在线观看| 成人毛片a级毛片在线播放| 国产一区二区亚洲精品在线观看| 建设人人有责人人尽责人人享有的 | 禁无遮挡网站| 久久久精品大字幕| 久久精品人妻少妇| 精品免费久久久久久久清纯| 欧美日本视频| 夜夜看夜夜爽夜夜摸| 免费播放大片免费观看视频在线观看 | 天天躁日日操中文字幕| 最近最新中文字幕大全电影3| 国产女主播在线喷水免费视频网站 | 久久热精品热| 综合色丁香网| 亚洲精品乱码久久久v下载方式| 欧美三级亚洲精品| 国产精品爽爽va在线观看网站| 久热久热在线精品观看| 伦理电影大哥的女人| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 精品人妻一区二区三区麻豆| 国产精品一区二区性色av| 免费观看人在逋| 欧美成人免费av一区二区三区| 日本-黄色视频高清免费观看| 成年女人永久免费观看视频| 建设人人有责人人尽责人人享有的 | 一级黄片播放器| 久久久久国产网址| 亚洲伊人久久精品综合 | 赤兔流量卡办理| 美女cb高潮喷水在线观看| 在线观看66精品国产| 天堂√8在线中文| 婷婷色av中文字幕| h日本视频在线播放| 日韩大片免费观看网站 | 嘟嘟电影网在线观看| 女人久久www免费人成看片 | 亚洲av不卡在线观看| 亚洲成人av在线免费| 国产亚洲午夜精品一区二区久久 | 97超视频在线观看视频| 精品无人区乱码1区二区| 亚洲精华国产精华液的使用体验| 欧美bdsm另类| 一区二区三区乱码不卡18| 欧美97在线视频| 黄片无遮挡物在线观看| 一个人观看的视频www高清免费观看| 精品国内亚洲2022精品成人| 日韩欧美精品v在线| 亚洲欧美清纯卡通| 亚洲无线观看免费| 少妇丰满av| 亚洲四区av| 国产精品不卡视频一区二区| 国产精品av视频在线免费观看| 亚洲国产精品成人久久小说| 亚洲在久久综合| 国产亚洲91精品色在线| 一级av片app| 一级黄色大片毛片| 国产一区二区亚洲精品在线观看| 国产在视频线精品| 精品久久久噜噜| 永久免费av网站大全| 久久久久久伊人网av| 亚洲欧美一区二区三区国产| 国产精品.久久久| 国产精品日韩av在线免费观看| 国产v大片淫在线免费观看| 亚洲中文字幕一区二区三区有码在线看| 我要看日韩黄色一级片| 国产综合懂色| 亚洲乱码一区二区免费版| 99久国产av精品国产电影| 国产精品99久久久久久久久| 精品人妻视频免费看| 午夜免费激情av| 国产亚洲精品av在线| 七月丁香在线播放| 成人鲁丝片一二三区免费| 最近中文字幕2019免费版| 成年女人永久免费观看视频| 中文字幕免费在线视频6| 91久久精品电影网| 少妇猛男粗大的猛烈进出视频 | 日本av手机在线免费观看| 久久精品熟女亚洲av麻豆精品 | 人体艺术视频欧美日本| 一级二级三级毛片免费看| 亚洲天堂国产精品一区在线| 亚洲乱码一区二区免费版| 18禁裸乳无遮挡免费网站照片| 国产伦理片在线播放av一区| 日韩大片免费观看网站 | www.av在线官网国产| 日本猛色少妇xxxxx猛交久久| a级毛色黄片| 麻豆久久精品国产亚洲av| 男女视频在线观看网站免费| 97超碰精品成人国产| 亚洲一级一片aⅴ在线观看| 麻豆av噜噜一区二区三区| 人妻夜夜爽99麻豆av| 少妇猛男粗大的猛烈进出视频 | 97热精品久久久久久| 91精品一卡2卡3卡4卡| 久久久久久久久久黄片| 一卡2卡三卡四卡精品乱码亚洲| 亚洲激情五月婷婷啪啪| av国产久精品久网站免费入址| 亚洲,欧美,日韩| 久久精品影院6| 成年av动漫网址| 国产熟女欧美一区二区| 久久久色成人| 伦精品一区二区三区| 99在线人妻在线中文字幕| 亚洲不卡免费看| 亚洲成人精品中文字幕电影| 1024手机看黄色片| 欧美激情国产日韩精品一区| 国产一区二区在线av高清观看| 亚洲国产精品国产精品| 久久99精品国语久久久| 久久国内精品自在自线图片| 精品酒店卫生间| 欧美一区二区亚洲| 又黄又爽又刺激的免费视频.| 在线观看一区二区三区| 超碰97精品在线观看| 亚洲精品乱码久久久久久按摩| 亚洲欧美清纯卡通| av福利片在线观看| 中文字幕熟女人妻在线| 国产精品久久久久久精品电影小说 | 狠狠狠狠99中文字幕| 日韩一区二区视频免费看| 99热网站在线观看| 国产一级毛片在线| 中文字幕av成人在线电影| 亚洲精品国产av成人精品| 亚洲国产精品合色在线| 淫秽高清视频在线观看| 十八禁国产超污无遮挡网站| 欧美bdsm另类| 欧美3d第一页| 边亲边吃奶的免费视频| 春色校园在线视频观看| 成人高潮视频无遮挡免费网站| 成人漫画全彩无遮挡| 国产又黄又爽又无遮挡在线| 久久国产乱子免费精品| 99热6这里只有精品| 成人毛片60女人毛片免费| 欧美成人一区二区免费高清观看| 特级一级黄色大片| 亚洲欧洲日产国产| 日本一本二区三区精品| 久久精品夜夜夜夜夜久久蜜豆| 人妻系列 视频| 久久精品人妻少妇| 精品一区二区三区视频在线| 美女脱内裤让男人舔精品视频| 女人十人毛片免费观看3o分钟| 国产精品不卡视频一区二区| 久久精品影院6| 老师上课跳d突然被开到最大视频| 五月伊人婷婷丁香| 啦啦啦啦在线视频资源| 日本五十路高清| 国产成人aa在线观看| 你懂的网址亚洲精品在线观看 | 人人妻人人澡人人爽人人夜夜 | 七月丁香在线播放| 亚洲人成网站在线播| 哪个播放器可以免费观看大片| 久久精品久久久久久久性| 亚洲精品日韩在线中文字幕| 久99久视频精品免费| 欧美三级亚洲精品| 亚洲精品影视一区二区三区av| 欧美激情国产日韩精品一区| or卡值多少钱| 久久这里有精品视频免费| 亚洲内射少妇av| 免费观看精品视频网站| 在线免费观看的www视频| 内地一区二区视频在线| www日本黄色视频网| 成人鲁丝片一二三区免费| 午夜日本视频在线| 国产精品一区www在线观看| 精品国产露脸久久av麻豆 | 亚洲一级一片aⅴ在线观看| 久久久久久久久久久丰满| 亚洲成人中文字幕在线播放| 国产精品国产三级国产专区5o | 麻豆精品久久久久久蜜桃| 2022亚洲国产成人精品| 免费黄色在线免费观看| 国产乱人视频| 亚洲欧美中文字幕日韩二区| 成人毛片60女人毛片免费| 亚洲四区av| 国产极品精品免费视频能看的| 国内精品宾馆在线| 国产极品精品免费视频能看的| 毛片女人毛片| 欧美区成人在线视频| 日本爱情动作片www.在线观看| 欧美变态另类bdsm刘玥| 97在线视频观看| 欧美变态另类bdsm刘玥| 九九热线精品视视频播放| 中文字幕久久专区| 一边亲一边摸免费视频| 久久久a久久爽久久v久久| 国产精品人妻久久久影院| 国产亚洲av片在线观看秒播厂 | 一区二区三区高清视频在线| 简卡轻食公司| 在线观看av片永久免费下载| 免费黄色在线免费观看| 久久久午夜欧美精品| 51国产日韩欧美| 又粗又爽又猛毛片免费看| 99热6这里只有精品| 神马国产精品三级电影在线观看| 麻豆精品久久久久久蜜桃| 国产精品国产三级专区第一集| 三级毛片av免费| 亚洲欧美精品专区久久| 免费看av在线观看网站| 深夜a级毛片| 亚洲人成网站在线播| 色综合亚洲欧美另类图片| 国产综合懂色| 丰满人妻一区二区三区视频av| 丝袜喷水一区| 国产精品一区二区三区四区久久| 成人综合一区亚洲| 97在线视频观看| 国产欧美日韩精品一区二区| 国产高清国产精品国产三级 | 中文字幕av成人在线电影| 秋霞在线观看毛片| 波多野结衣高清无吗| 热99re8久久精品国产| 亚洲精品亚洲一区二区| 国产视频内射| 亚洲精品日韩av片在线观看| 欧美另类亚洲清纯唯美| 国产精品av视频在线免费观看| 尤物成人国产欧美一区二区三区| 丰满人妻一区二区三区视频av| 免费观看精品视频网站| 有码 亚洲区| 国产成人午夜福利电影在线观看| 日韩强制内射视频| 久久亚洲国产成人精品v| 久久99热这里只频精品6学生 | 国产伦一二天堂av在线观看| a级毛片免费高清观看在线播放| 日韩成人伦理影院| 在线观看美女被高潮喷水网站| 免费看光身美女| 久久韩国三级中文字幕| 三级男女做爰猛烈吃奶摸视频| 亚洲五月天丁香| 免费观看在线日韩| 成人av在线播放网站| 神马国产精品三级电影在线观看| 国产中年淑女户外野战色| 日日啪夜夜撸| 国产精品蜜桃在线观看| 国产精品久久久久久精品电影| 国产高清三级在线| 国产黄a三级三级三级人| kizo精华| 国产高清有码在线观看视频| 九草在线视频观看| 18禁在线无遮挡免费观看视频| 你懂的网址亚洲精品在线观看 | 精品一区二区三区人妻视频| 国产老妇伦熟女老妇高清| 中文字幕av成人在线电影| 成人鲁丝片一二三区免费| 黄片wwwwww| 国产综合懂色| 男女国产视频网站| 免费看光身美女| 亚洲国产最新在线播放| 亚洲国产高清在线一区二区三| 国产美女午夜福利| 国产极品天堂在线| 免费看日本二区| 草草在线视频免费看| 天堂网av新在线| 狂野欧美激情性xxxx在线观看| 九草在线视频观看| 男人和女人高潮做爰伦理| 日日啪夜夜撸| 亚洲久久久久久中文字幕|